Document is current
Any future updates will be listed below
-
Authors
Li, Yang
Yadollahi, Pedram
Essien, Fonma N.
Putluri, Vasanta
Ambati, Chandra Shekar R.
Kami Reddy, Karthik Reddy
Kamal, Abu Hena Mostafa
Putluri, Nagireddy
Abdurrahman, Lama M.
Ruiz Echartea, Maria E.
Ernste, Keenan J.
Trivedi, Akshar J.
Vazquez-Perez, Jonathan
Hudson, William H.
Decker, William K.
Patel, Rutulkumar
Osman, Abdullah. A.
Kheradmand, Farrah
Lai, Stephen Y.
Myers, Jeffrey N.
Skinner, Heath D.
Coarfa, Cristian
Lee, Kwangwon
Jain, Antrix
Malovannaya, Anna
Frederick, Mitchell J.
Sandulache, Vlad C. https://orcid.org/0000-0002-9205-385X
-
Funding
Funding for this research was provided by:
Office of Extramural Research, National Institutes of Health (R01CA280980)
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 17 February 2025
First Online: 5 April 2025
Declarations
:
: All animal work performed in the current manuscript was in accordance with the rules of the Baylor College of Medicine Institutional Animal Care and Use Committee.
: Not applicable.
: The authors report no conflicts of interest relevant to the work summarized in the current manuscript. V.C.S. is a consultant and equity holder in Femtovox Inc. and a consultant for PDS Biotechnology. S.Y.L. is a medical affairs consultant for Cardinal Health. W.K.D. holds an ownership stake in and is a paid advisor of the Diakonos Oncology Corporation. W.K.D also disclosed his role as a paid advisor of APAC Biotech, Pvt, Ltd from 2015 to 2020. All other authors declare no conflicts of interest. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.
